Amlesh Seth
Overview
Explore the profile of Amlesh Seth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
1675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh P, Ghorai R, Seth A, Saini S
BMJ Case Rep
. 2025 Mar;
18(3).
PMID: 40032563
A man in his 50s presented to the emergency department with a complaint of progressively increasing swelling in the lower abdomen. Investigations revealed a large pelvic mass for which a...
2.
Arulraj K, Sharma S, Das C, Seth A, Kumar R
Prostate Int
. 2025 Jan;
12(3):128-133.
PMID: 39816937
Introduction: Up to 40% of patients with suspected prostate cancer (PCa) have a negative prebiopsy magnetic resonance imaging (nMRI), and up to 15% of them may have clinically significant PCa...
3.
Khandakar H, Kaushal S, Seth A, Sahoo R, Narwal A, Jangir H, et al.
Am J Clin Pathol
. 2025 Jan;
PMID: 39805149
Objectives: Immune checkpoint inhibitors have revolutionized treatment of platinum-refractory advanced bladder cancer, offering hope where options are limited. Response varies, however, influenced by factors such as the tumor's immune microenvironment...
4.
Kumar S, Nayyar R, Jain S, Seth A, Kaushal S
Urol Oncol
. 2025 Jan;
PMID: 39800633
Background: The role of repeat transurethral resection of bladder tumor (TURBT) for the management of nonmuscle invasive bladder carcinoma is debated, especially when initial resections include detrusor muscle. This study...
5.
Kumar L, Nayyar R, Nayak B, Singh P, Kumar R, Seth A
J Minim Access Surg
. 2024 Nov;
PMID: 39611569
Introduction: To evaluate the feasibility, safety, and effectiveness of different pyeloplasty procedure approaches for pelvicureteric junction (PUJ) obstruction in kidney anomalies. The presence of difficult, unfamiliar and anomalous anatomy makes...
6.
Jangir H, Narwal A, Adhikari S, Batra A, Nayak B, Seth A, et al.
Cytopathology
. 2024 Nov;
36(2):140-149.
PMID: 39562500
Objective: The objective of this study is to evaluate the diagnostic performance of urine cytology using The Paris System (TPS 2.0) in comparison with TPS 1.0, and the Four-Tier Reporting...
7.
Sachan A, Nayyar R, Pethe S, Singh P, Seth A
World J Urol
. 2024 Oct;
42(1):609.
PMID: 39480527
Introduction: To evaluate the efficacy and side effects of re-circulant hyperthermic intravesical chemotherapy versus conventional treatments for intermediate risk non-muscle invasive bladder cancer (NMIBC). Methods: A randomized 3-arm, parallel group...
8.
Mittal C, Gupta H, Nagpal C, Sahoo R, Sharma A, Gangadharaiah B, et al.
Curr Oncol
. 2024 Sep;
31(9):4940-4954.
PMID: 39329994
Introduction: Prostate cancer is one of the most prevalent malignancies affecting men globally, with a significant impact on health-related quality of life (HRQOL). With the recent therapeutic advancements and improvements...
9.
Arulraj K, Quadri J, Nayak B, Pandit S, Panayadiyan S, Singh P, et al.
Urol Oncol
. 2024 Sep;
43(1):66.e19-66.e28.
PMID: 39294077
Introduction: Heavy metals exposure is a known carcinogen in humans. The impact of heavy metals in the pathogenesis of renal cell carcinoma (RCC) is unclear with scant available literature. Though...
10.
Singh P, Sachan A, Nayak B, Nayyar R, Kumar R, Seth A
Indian J Surg Oncol
. 2024 Sep;
15(3):563-571.
PMID: 39239430
The evidence on bladder cancer in the young population remains fragmented due to lack of literature and conflicting results from the existing studies. We aim to elucidate such conflicting data...